Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01032759 · ClinicalTrials.gov registry record · Phase 4
Memantine and Postoperative Pain
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 77
- Enrollment target
NCT01032759 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 77 participants.
The verdict
NCT01032759, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 77 participants
- Enrollment target
Study Summary
Memantine is associated with improvement in pain relief after surgery.
Interventions
- DRUG Placebo
- DRUG Memantine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2009-12 |
| Est. Completion | 2015-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01032759
The ClinicalTrials.gov registry entry for NCT01032759 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01032759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01032759 about?
NCT01032759 is a clinical study titled "Memantine and Postoperative Pain". Memantine is associated with improvement in pain relief after surgery.
What is the current status of trial NCT01032759?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 77 participants. The study started on 2009-12. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01032759?
The interventions under investigation include: Placebo (DRUG), Memantine (DRUG).
Who is sponsoring clinical trial NCT01032759?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.